Stay current with all the latest and breaking news about Novo Nordisk's, compare headlines and perspectives between news sources on stories happening today. In total, 15 stories have been published about Novo Nordisk's which Ground News has aggregated in the past 3 months.
Reuters
•India plans incentives for diabetes, obesity drug makers in 2026, government official says
View summary
Reuters
•Novo Nordisk's Wegovy weight-loss drug approved in China
View summary
CNBC
•Novo Nordisk's Wegovy weight loss drug approved in China
View summary
Reuters
•Wegovy-maker Novo Nordisk to spend $4.1 billion to boost US manufacturing
Read full article
Reuters
•Doctors must keep prescriptions for Ozempic in check, Danish regulator says
Read full article
Reuters
•Novo's Wegovy induces higher weight loss in women than men with same heart condition, study shows
Read full article
CNBC
•Weight loss drug contender Zealand Pharma jumps 23% on trial results
View summary
Reuters
•Weight-loss options for US youth are hard to come by
View summary
CNBC
•Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
View summary
Reuters
•About 3.6 million Medicare beneficiaries could be eligible for Wegovy coverage, study shows
View summary
CNBC
•Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
View summary
Reutersagency
•Novo Nordisk says experimental drug amycretin show 13% weight loss in trial | Reuters News Agency
View summary
CNBC
•Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
View summary
CNBC
•Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
View summary
Reuters
•Novo Nordisk's kidney trial shows 24% cut to cardiac risk, death
View summary